Small conductance calcium-activated potassium channel current, IKCa, has recently been characterized in atrial tissue and linked with atrial arrhythmogenesis. As IKCa does not contribute significantly to the ventricular action potential, there is great interest in developing pharmacological agents targeting these channels. However, experimental data so far have presented conflicting evidence as to whether IKCa inhibition is pro-or anti-arrhythmic.
Introduction
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, affecting 3% of the adult population of developed countries. AF is associated with increased morbidity and mortality and its incidence is expected to rise in the near future, making it an urgent and important health problem [1] .
Although anti-arrhythmic drugs (AADs) are the first line therapy for recent onset AF, their cardioversion efficacy can be as low as 50% [1] . AADs often carry significant side effects, namely the potential to induce lifethreatening ventricular arrhythmias. These pro-arrhythmic side effects can be minimised if AADs are designed to target atrial-selective ionic channels, which have a negligible contribution to the ventricular action potential.
One of such targets is the K + ultra-rapid delayed rectifier current, IKur, which is expressed in human atrial cells, but not in human ventricles [2] . This is in contrast with the rapid delayed rectifier current, IKr, which is ubiquitous throughout the heart and the blockade of which may lead to life-threatening Torsade de Pointes [2] .
Recently, ionic current carried by small-conductance calcium-dependent K + channels, IKCa, has been characterised in human and canine atrial cells, but, significantly, not in ventricular myocytes, making IKCa a potentially desirable target of anti-arrhythmic drug action in AF. Genomic associations between IKCa and AF have also been established [3] .
Although blocking IKCa is known to increase the action potential duration (APD) in canine atrial cells [3] - [6] , there is some controversy as to whether its blockade is proor anti-arrhythmic. Blocking IKCa has been found to facilitate the initiation of atrial arrhythmias [3] , [6] , by increasing both APD and APD heterogeneity in the canine left atrium (LA). Other studies have instead found that IKCa blockade, through prolongation of APD, led to reduced AF duration [4] and AF termination [5] . It is also at the moment not clear whether IKCa is overexpressed in the presence of AF remodelling [4] or not [7] .
In this paper, we aim to reconcile the disparate experimental findings about IKCa's effect on AF using insights from computational models. To this end, we introduce a new mathematical formulation for IKCa and include it in our recently developed canine atrial cell models [8] . We use these updated canine models to investigate the effect on APD of blockades of IKr, IKur and IKCa in several atrial remodelling conditions. We then determine the effectiveness of these blockades in realistic 3D canine atrial models [8] and interpret these findings in the light of the drugs' effects on APD and APD dispersion across the entire atria, using the formalism previously applied to investigate the effectiveness of multi-channelblocking AADs [8] .
3.

Methods
Canine Model of Atrial Fibrillation
In this study we used the 3D canine model successfully employed to study the efficacy of AADs in atrial fibrillation [8] , [9] . This model includes a realistic canine atrial geometry and myofibre orientations derived from micro computed tomography [10] . It also includes four region-specific electrophysiological models and can easily incorporate different degrees of AF-induced ionic and structural remodelling [8] .
As in the previous study, we solved the monodomain equation in a central finite differences setting with t = 5
s and x = 0.3 mm. Conditions mimicking AF were obtained by pacing with an S1-S2 protocol near the pulmonary veins (PV) in the presence of moderate or severe ionic remodelling (see [8] , [9] for details). We additionally studied a situation of moderate remodelling in the presence of IKCa, according to the new mathematical formulation of this current presented below.
Formulation of IKCa in Heart Failure
The atrial IKCa was formulated as a time-independent passive K + current whose conductance depends strongly on the intracellular calcium concentration, [Ca 2+ ]i, following a Hill equation [11] , [12] . Parameterization was achieved by fitting experimental data from isolated ventricular myocytes from HF patients [11] , to give Equation (1):
with gKCa = 0.07 pA/pF, n = 5.0 and Kd = 3 x 10 -4 mM. Vm is the transmembrane electrical potential, and EK is the reversal potential for K + ions, typically around -87 mV.
Modelling the Action of AADs
The initial simulations of AF were run for 5 s, at which time each of the AADs was administered. Each drug action was responsible for an instantaneous 50% block of: 1) IKr; 2) IKur or, when the model included it, 3) IKCa. The electrical activity of the atrial model was followed for 5s or until termination of all re-entrant activity.
To shed light into the mechanisms through which AAD action is facilitated, we computed 90% action potential duration, ADP90, in baseline conditions (canine models [8] with IKCa) and in the presence of 50% block of either: 1) IKr, 2) IKur and 3) IKCa. This was performed for a basic cycle length (BCL) of 500 ms in single-cells and in realistic 3D atrial models. In the latter case, the canine atrial model was paced twice at 150 ms near the left superior PV before APD in each voxel of the model.
Results
AAD effects in a 3D Model of AF
In our AF model of moderate ionic remodelling, IKr blockade did not have a significant effect on AF, whereas IKur blockade led to the creation of an additional rotor in the right atrium (RA). In the advanced AF model, AF was sustained by four rotors in total (Figure 1 ). Neither IKr nor IKur blockade had a significant effect in any of the rotors. The IKCa blockade terminated AF within 500 ms. Both IKr and IKur blockades increased the complexity of AF activations, leading to the formation of an additional rotor in each atrial appendage (RAA and LAA). The outcomes of these simulations are summarised in Table 1 . The rotor divides into two.
IKur
A new rotor appears in the RAA.
No change.
The rotor divides into two.
IKCa
--
All activity is terminated at < 500 ms.
Effect on APD and APD Heterogeneity
To interpret the different behaviour of the re-entrant activity in the presence of the AADs in the 3D simulations, we analysed the effect of the AADs on atrial refractoriness, as measured by APD90. Figure 2a shows the increase in single-cell APD90 values for different cell types (RA, LA, Bachmann's bundle and PV) in the presence of the IKCa formulation of Eq. (1) for the two levels of ionic remodelling. It is clear that the IKCa block led to the greatest rise in APD90, with IKr and IKur having a nearly insignificant effect on APD at the studied pacing rates. The IKCa block also enhances the heterogeneity in APD across cell types, particularly for conditions of moderate remodelling. Figure 2 . Effect of the 50% blockade of different ionic channels on APD90 values for the atrial canine model [8] in the presence of IKCa (Eq. (1) ) for moderate ionic remodelling. a) Increase in single-cell APD90 for each cell type for each AAD (BCL: 500 ms). b) Histogram of APD90 in atrial tissue in baseline conditions and after the administration of each AAD (BCL: 150 ms). c) APD90 maps in baseline conditions and in the presence of each ionic channel blocker (BCL: 150 ms).
Conclusions
In this paper, we extended the computational framework previously presented to study the action of AADs in a realistic 3D model of AF to include the small-conductance calcium-dependent K + channel recently characterized in atrial myocytes. Using the new model, we found that blocking IKCa was very effective at terminating AF, in contrast to inhibition of either IKur or IKr, which were proarrhythmic in these circumstances (Table 1) . Even in the absence of IKCa, blocking IKur or IKr did not lead to termination in either of the investigated stages of AF remodelling ( Table 1 ).
The differences in the effectiveness of these drugs can be explained by their effect on atrial APD. We found that blocking IKCa led to both an increase in APD and APD dispersion (Figure 2 ), in contrast with blocks of either IKr or IKur, which hardly affected APD in the analysed conditions. We thus hypothesise that the effectiveness of the IKCa block lies in the increase in APD (and therefore wavelength) that it generates. As in Moe's classical theory, this leads to a decrease in the critical volume available to the existing re-entrant circuits, terminating them [13] .
In the analysed circumstances, the substantial increase in APD (of more than 60 ms, Figure 2a ) brought about by IKCa's block trumps the concomitant pro-arrhythmic increase in APD dispersion. It is likely that the APD90 dispersion induced by IKCa is, at least in part, mediated by the very heterogeneous distribution of Cai across the atria, as seen in Figure 1 . This is in contrast to the AAD actions studied previously [8] , whose effectiveness was dominated by their effect on APD dispersion over APD prolongation. We propose that the effectiveness of IKCa blockers may depend on the balance between these two anti-arrhythmic and proarrhythmic effects. In cases when the APD prolongation dominates (as remodelling conditions in the current study), a block of IKCa is likely to be beneficial. This agrees with anti-arrhythmic effects of IKCa blockade observed in dogs exposed to prolonged atrial pacing [4] . However, if the dispersion in APD it induces is the dominant effect, it is likely that an APD block may be pro-arrhythmic, as seen non-remodelled canine atria [3] . These hypotheses, as well as the congruent earlier ones [14] , will be tested in greater detail in future computational studies.
The current study has some limitations. The AAD actions do not model the action of known compounds, instead focusing on mechanisms of drug action. Ion channel state-dependent binding is therefore not taken into account. We have additionally assumed that the drug action was instantaneous, which is a simplification.
In summary, the current study presents a novel formulation for IKCa, which was incorporated into existing state of the art canine atrial models. We use these updated electrophysiology models to investigate the effectiveness of IKCa blockade in comparison to blockades of other K + channels: IKr and IKur. We explain the superiority of IKCa blockade by showing how it leads to an increase in APD. The IKCa blockade causes, nevertheless, an increase in APD dispersion, which, in some circumstances, may be proarrhythmic, as has been shown in experimental studies.
